New-onset cardiovascular risk factors in lung transplant recipients

Journal of Heart and Lung Transplantation

Volumn 24, Issue 10, 2005, Pages 1536-1543

  Silverborn, Martin ^a   Jeppsson, Anders ^a   Mårtensson, Gunnar ^a   Nilsson, Folke ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CHOLESTEROL; CYCLOSPORIN; GLUCOSE; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; BRONCHIOLITIS OBLITERANS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONFIDENCE INTERVAL; CYSTIC FIBROSIS; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE PREDISPOSITION; FEMALE; GRAFT REJECTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRICHOSIS; IMMUNOSUPPRESSIVE TREATMENT; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POSTOPERATIVE PERIOD; PREVALENCE; PRIORITY JOURNAL; RECIPIENT; RETROSPECTIVE STUDY; STATISTICAL MODEL;

ADULT; CAUSALITY; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HEART TRANSPLANTATION; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; IMMUNOSUPPRESSIVE AGENTS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RESPIRATORY INSUFFICIENCY; RETROSPECTIVE STUDIES; RISK FACTORS; TRANSPLANTATION;

EID: 25844516660     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2005.01.004     Document Type: Article

References (29)

1. B.L. Kasiske Epidemiology of cardiovascular disease after renal transplantation Transplantation 72 suppl 2001 5 8
2. P. Gallo, L. Agozzino, A. Angelini Causes of late failure after heart transplantation a 10-year survey J Heart Lung Transplant 16 1997 1113 1121
3. S. Asfar, P. Metrakos, J. Fryer An analysis of late deaths after liver transplantation Transplantation 61 1996 1377 1381
4. E.P. Trulock, L.B. Edwards, D.O. Taylor The registry of the International Society for Heart and Lung Transplantation twentieth official adult lung and heart-lung transplant report - 2003 J Heart Lung Transplant 22 2003 625 635
5. Y. Sekine, T.K. Waddell, A. Matte-Martyn Risk quantification of early outcome after lung transplantation donor, recipient, operative and post-transplant parameters J Heart Lung Transplant 23 2004 96 104
6. O. Guckelberger, W.O. Bechstein, R. Neuhaus Cardiovascular risk factors in long-term follow-up after orthotopic liver transplantation Clin Transplant 11 1997 60 65
7. H.A. Koomans, G. Ligtenberg Mechanisms and consequences of arterial hypertension after renal transplantation Transplantation 72 suppl 2001 9 12
8. P. Marchetti New-onset diabetes after transplantation J Heart Lung Transplant 23 suppl 2004 194 201
9. N. Shiba, M.C. Chan, H.A. Valantine Longer-term risks associated with 10-year survival after heart transplantation in the cyclosporine era J Heart Lung Transplant 22 2003 1098 1106
10. L.W. Miller Cardiovascular toxicities of immunosuppressive agents Am J Transplant 2 2002 807 818
11. J.M. Cecka The UNOS renal transplant registry Clin Transpl 2002 1 20
12. D.O. Taylor, L.B. Edwards, P.J. Mohacsi The registry of the International Society for Heart and Lung Transplantation twentieth official adult heart transplant report - 2003 J Heart Lung Transplant 22 2003 616 624
13. R. Adam, P. McMaster, J.G. O'Grady Evolution of liver transplantation in Europe report of the European Liver Transplant Registry Liver Transplant 9 2003 1231 1243
14. M. Rice, J. Martin, D. Hathaway, E. Tolley Prevalence of cardiovascular risk factors before kidney transplantation Progr Transplant 12 2002 299 304
15. A.H. Mokdad, E.S. Ford, B.A. Bowman Diabetes trends in the U.S 1990-1998 Diabetes Care 23 2000 1278 1283
16. G.H. Jenkins, D.R. Singer Hypertension in thoracic transplant recipients J Hum Hypertens 12 1998 813 823
17. H.O. Ventura, F.S. Malik, M.R. Mehra, D.D. Stapleton, F.W. Smart Mechanisms of hypertension in cardiac transplantation and the role of cyclosporine Curr Opin Cardiol 12 1997 375 381
18. S.J. Taler, S.C. Textor, V.J. Canzanello, L. Schwartz Cyclosporin-induced hypertension incidence, pathogenesis and management Drug Safety 20 1999 437 449
19. C. Bracht, X.W. Yan, H.P. LaRocca, G. Sutsch, W. Kiowski Cyclosporine A and control of vascular tone in the human forearm influence of post-transplant hypertension J Hypertens 17 1999 357 363
20. A. Silverborn M Ambring, F. Nilsson, P. Friberg, A. Jeppsson Increased arterial stiffness in normotensive cyclosporine-treated lung transplant recipients Clin Transplant 18 2004 473 479
21. Silverborn M, Ambring A, Nilsson F, Friberg P, Jeppsson A. Blunted vascular response to endothelin-A receptor blockade in cyclosporine-treated lung transplant recipients. J Heart Lung Transplant (in press).
22. F. Akhlaghi, C.H. Jackson, J. Parameshwar, L.D. Sharples, A.K. Trull Risk factors for the development and progression of dyslipidemia after heart transplantation Transplantation 73 2002 1258 1264
23. B. Bastani, S. Robinson, T. Heisler Post-transplant hyperlipidemia risk factors and response to dietary modification and gemfibrozil therapy Clin Transplant 4 1995 340 348
24. J.A. Kobashigawa, S. Katznelson, H. Laks Effect of pravastatin on outcomes after cardiac transplantation N Engl J Med 333 1995 621 627
25. B.A. Johnson, A.T. Iacono, A. Zeevi, K.R. McCurry, S.R. Duncan Statin use is associated with improved function and survival of lung allografts Am J Respir Crit Care Med 167 2003 1271 1278
26. M.M. Chakinala, E.P. Trulock Acute allograft rejection after lung transplantation diagnosis and therapy Chest Surg Clin N Am 13 2003 525 542
27. A. Asberg Interactions between cyclosporin and lipid-lowering drugs implications for organ transplant recipients Drugs 63 2003 367 378
28. H. Valantine, P. Rickenbacker, M. Kemna Metabolic abnormalities characteristic of dysmetabolic syndrome predict the development of transplant coronary artery disease a prospective study Circulation 103 2001 2144 2152
29. A. Moran, D. Hardin, D. Rodman Diagnosis, screening and management of cystic fibrosis related diabetes mellitus a consensus conference report Diabetes Res Clin Pract 45 1999 61 73